Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109230) titled 'SPF of Iberia Photosafe Hybrid Sunscreen Gel' on April 23.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Iberia Pharmaceuticals India Ltd.
Intervention:
Intervention1: Test Product: Photosafe Hybrid Sunscreen Gel: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Recruitment Status:...